Physician profile
Brion Moran
NPI 1174528970
$3,315.98
in general payments reported to CMS, 2019-2025
10 companies · $53.16 in 2025
The $53.16 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,182 · 2020: $188 · 2021: $770 · 2022: $74.80 · 2023: $21.31 · 2024: $26.49 · 2025: $53.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,417.61 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed |
| Wright Medical Technology, INC. | $692.25 | 2019 | |
| Zimmer Biomet Holdings, INC. | $663.88 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $203.51 | 2019-2022 | |
| Depuy Synthes Sales INC. | $147.52 | 2021-2024 | Na, Va-Lcp |
| Dynasplint Systems INC. | $102.49 | 2021 | |
| Sanofi-Aventis U.S. LLC | $46.44 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $16.32 | 2025 | |
| Pacira Therapeutics, INC. | $13.05 | 2019 | |
| Medtronic USA, INC. | $12.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brion Moran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.